{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:35:02Z","timestamp":1778657702201,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KC2310"],"award-info":[{"award-number":["01KC2310"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pancreatic cancer is the third leading cause of cancer-related death in Northern America and fourth in Europe. Emerging evidence suggests that the pancreatic microbiome may play a significant role in the development and progression of this disease. Although the human microbiota contributes to health by supporting nutritional and hormonal homeostasis, modulating inflammation, detoxifying harmful compounds, and producing beneficial metabolites, several studies have implicated its crucial modulatory role in numerous diseases, including cancer. The main objective of this review is to investigate the specific relationship between the microbiome and pancreatic carcinogenesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A comprehensive literature search will identify studies examining the microbiome in human samples of saliva, pancreatic fluid, bile, pancreatic tissue, and feces of patients with chronic pancreatitis, precancerous pancreatic lesions, and pancreatic cancer. Studies differentiating bacteria to at least the genus level will be prioritized. Eligible studies include randomized controlled trials and observational studies analyzing the human microbiome in patients with chronic pancreatitis, pancreatic precursor lesions, or pancreatic cancer compared to healthy controls. Studies analyzing nonhuman samples, single bacterial strains, or lacking comparator groups will be excluded. The following databases will be searched without any restrictions to the publication date up until December 2024: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), Embase, and Web of Science. Animal studies, case reports, and studies not reporting analyses of human samples are excluded. Details regarding blinding, risk of bias, and funding sources will be extracted and assessed. The main outcomes include the bacterial diversity in each sample type (stool, saliva, bile, intratumoral, and tissue) itemized for each diagnosis, identifying differentially abundant or depleted taxa, and evaluating the correlation of specific bacteria with disease prevention or progression and clinical outcomes. Data extraction will be performed independently by two reviewers. Risk-of-bias assessment will be performed using Cochrane tools appropriate for each study design. Comparisons will be analyzed by descriptive statistics, and meta-analyses will be performed when applicable. The review will be conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>In summary, this systematic review aims to synthesize studies analyzing microbiome profiles in patients with chronic pancreatitis, precursor lesions, and pancreatic cancer, focusing on identifying bacterial diversity and specific taxa related to disease progression and development of cancer in comparison to healthy controls and will include a thorough critical appraisal of the available literature. Anticipated limitations include heterogeneity in microbiome sampling methods and potential variability in taxonomic resolution across studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Systematic review registration<\/jats:title>\n            <jats:p>PROSPERO CRD42023487995.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13643-025-02910-3","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:48:39Z","timestamp":1752832119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of the MicroBiome in PANCreatic cancer and its precursors\u2014 the study protocol of the MiBiPanc systematic review and meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"My-Lan","family":"Pianka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Werba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes A.","family":"Vey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kalkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solveig","family":"Tenckoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Tony-Odigie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph W.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-9339","authenticated-orcid":false,"given":"Frank","family":"Pianka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"3","key":"2910_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2910_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2910_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2013.08.015","volume":"345","author":"AV Pinho","year":"2014","unstructured":"Pinho AV, Chantrill L, Rooman I. Chronic pancreatitis: a path to pancreatic cancer. Cancer Lett. 2014;345(2):203\u20139.","journal-title":"Cancer Lett"},{"issue":"10","key":"2910_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1159\/000493554","volume":"41","author":"JY Kim","year":"2018","unstructured":"Kim JY, Hong SM. Precursor lesions of pancreatic cancer. Oncol Res Treat. 2018;41(10):603\u201310.","journal-title":"Oncol Res Treat"},{"issue":"6","key":"2910_CR5","first-page":"3163","volume":"11","author":"H Matsukawa","year":"2021","unstructured":"Matsukawa H, Iida N, Kitamura K, Terashima T, Seishima J, Makino I, et al. Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors. Am J Cancer Res. 2021;11(6):3163\u201375.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"2910_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.pan.2018.03.005","volume":"18","author":"QX Mei","year":"2018","unstructured":"Mei QX, Huang CL, Luo SZ, Zhang XM, Zeng Y, Lu YY. Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls. Pancreatology. 2018;18(4):438\u201345.","journal-title":"Pancreatology"},{"issue":"9","key":"2910_CR7","first-page":"959","volume":"28","author":"SH Olson","year":"2017","unstructured":"Olson SH, Satagopan J, Xu Y, Ling L, Leong S, Orlow I, et al. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Cancer Causes Control. 2017;28(9):959\u201369.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2910_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795-806.e12.","journal-title":"Cell"},{"issue":"7402","key":"2910_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Consortium HMP","year":"2012","unstructured":"Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207\u201314.","journal-title":"Nature"},{"issue":"7706","key":"2910_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557(7706):580\u20134.","journal-title":"Nature"},{"issue":"2","key":"2910_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"2910_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00248-013-0245-9","volume":"66","author":"N Wu","year":"2013","unstructured":"Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol. 2013;66(2):462\u201370.","journal-title":"Microb Ecol"},{"key":"2910_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","volume":"15","author":"A Borrelli","year":"2018","unstructured":"Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, et al. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biol. 2018;15:467\u201379.","journal-title":"Redox Biol"},{"issue":"5","key":"2910_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell. 2019;176(5):998-1013.e16.","journal-title":"Cell"},{"issue":"5","key":"2910_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/gutjnl-2023-330941","volume":"73","author":"E Saba","year":"2024","unstructured":"Saba E, Farhat M, Daoud A, Khashan A, Forkush E, Menahem NH, et al. Oral bacteria accelerate pancreatic cancer development in mice. Gut. 2024;73(5):770\u201386.","journal-title":"Gut"},{"issue":"1","key":"2910_CR16","doi-asserted-by":"publisher","first-page":"1983101","DOI":"10.1080\/19490976.2021.1983101","volume":"13","author":"A Halimi","year":"2021","unstructured":"Halimi A, Gabarrini G, Sobkowiak MJ, Ateeb Z, Davanian H, Gaiser RA, et al. Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties. Gut Microbes. 2021;13(1):1983101.","journal-title":"Gut Microbes"},{"issue":"5","key":"2910_CR17","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1021\/acs.jproteome.1c00018","volume":"20","author":"A Morgell","year":"2021","unstructured":"Morgell A, Reisz JA, Ateeb Z, Davanian H, Reinsbach SE, Halimi A, et al. Metabolic characterization of plasma and cyst fluid from cystic precursors to pancreatic cancer patients reveal metabolic signatures of bacterial infection. J Proteome Res. 2021;20(5):2725\u201338.","journal-title":"J Proteome Res"},{"issue":"10","key":"2910_CR18","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1097\/JS9.0000000000001762","volume":"110","author":"N Merali","year":"2024","unstructured":"Merali N, Chouari T, Sweeney C, Halle-Smith J, Jessel MD, Wang B, et al. The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Int J Surg. 2024;110(10):6771\u201399.","journal-title":"Int J Surg"},{"issue":"4","key":"2910_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403\u201316.","journal-title":"Cancer Discov"},{"issue":"1","key":"2910_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12866-024-03371-9","volume":"24","author":"H Jiang","year":"2024","unstructured":"Jiang H, Tian Y, Xu L, Chen X, Huang Y, Wu J, et al. Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients. BMC Microbiol. 2024;24(1):235.","journal-title":"BMC Microbiol"},{"issue":"1","key":"2910_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12866-022-02557-3","volume":"22","author":"M Kirishima","year":"2022","unstructured":"Kirishima M, Yokoyama S, Matsuo K, Hamada T, Shimokawa M, Akahane T, et al. Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis. BMC Microbiol. 2022;22(1):147.","journal-title":"BMC Microbiol"},{"issue":"12","key":"2910_CR22","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1136\/gutjnl-2018-317458","volume":"68","author":"RA Gaiser","year":"2019","unstructured":"Gaiser RA, Halimi A, Alkharaan H, Lu L, Davanian H, Healy K, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019;68(12):2186\u201394.","journal-title":"Gut"},{"key":"2910_CR23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"6","key":"2910_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00423-021-02204-x","volume":"406","author":"E Kalkum","year":"2021","unstructured":"Kalkum E, Klotz R, Seide S, H\u00fcttner FJ, Kowalewski KF, Nickel F, et al. Systematic reviews in surgery-recommendations from the Study Center of the German Society of Surgery. Langenbecks Arch Surg. 2021;406(6):1723\u201331.","journal-title":"Langenbecks Arch Surg"},{"key":"2910_CR25","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook."},{"key":"2910_CR26","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"10","key":"2910_CR27","doi-asserted-by":"publisher","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KG Moons","year":"2014","unstructured":"Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.","journal-title":"PLoS Med"},{"issue":"1","key":"2910_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51\u20138.","journal-title":"Ann Intern Med"},{"key":"2910_CR29","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"7650","key":"2910_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"key":"2910_CR31","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1038\/ncomms9727","volume":"6","author":"G Nakatsu","year":"2015","unstructured":"Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun. 2015;6:8727.","journal-title":"Nat Commun"},{"key":"2910_CR32","doi-asserted-by":"publisher","first-page":"26337","DOI":"10.1038\/srep26337","volume":"6","author":"Y Lu","year":"2016","unstructured":"Lu Y, Chen J, Zheng J, Hu G, Wang J, Huang C, et al. Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep. 2016;6:26337.","journal-title":"Sci Rep"},{"issue":"1","key":"2910_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1756283X12454590","volume":"6","author":"J Bien","year":"2013","unstructured":"Bien J, Palagani V, Bozko P. The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therap Adv Gastroenterol. 2013;6(1):53\u201368.","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"2910_CR34","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","volume":"22","author":"AK DeGruttola","year":"2016","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137\u201350.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02910-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:54:45Z","timestamp":1757253285000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2910"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02910-3","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}